Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Elif Yilmazel Uçar (Erzurum, Turkey), Elif Yilmazel Ucar, Alev Lazoglu Ozkaya, Omer Araz, Metin Akgun, Mehmet Meral, Hasan Kaynar, Leyla Saglam, Hulya Aksoy, Fatih Akcay. Serum and bronchial aspiration fluid HE-4 levels in lung cancer. Eur Respir J 2015; 46: Suppl. 59, 4272

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of IL-33 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Evaluation of IL-10 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC) Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Surfactant changes in patients with lung cancer underwent to resection Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Prevalence of preinvasive bronchial lesions in patients with lung cancer Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Bronchoscopic semantics and diagnosis of lung cancer Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Dividing EBUS-TBNA samples for simultaneous histopathological and molecular analyses in lung cancer patients Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology Year: 2015 The level of bronchoalveolar lavage fluid prostaglandine E2; Is it diagnostic of bronchogenic carcinoma? Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 MUC1 gene polymorphism and serum KL-6 in lung adenocarcinoma Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Evaluation of response to chemotherapy with fiberoptic bronchoscopy in lung cancers Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Osteopontin levels in sputum supernatant and serum of patients with lung cancer: Does coexistent COPD make the difference? Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Visible tumour on bronchoscopy: Do we need cytology? Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 The protein DJ-1 in malignant pleural effusions due to lung cancer: Levels and correlations with oxidative stress biomarkers Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Potential lung cancer biomarkers from bronchoalveolar lavage fluid using metabolomics approaches Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Cytotoxic phenotype of alveolar lymphocytes (AL) in bronchoalveolar lavage fluid (BALF) from non-small cell lung cancer (NSCLC) patients Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Metabolomic analysis of serum samples from patients with lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Lymphocyte profile in the BALF from affected lung in comparison to healthy lung and systemic inflammation in lung cancer Source: International Congress 2016 – Lung cancer and immune cells: friends or foes? Year: 2016 Molecular analysis of peripheral non-squamous non-small cell lung cancer sampled by radial EBUS Source: International Congress 2016 – Endosonography: EBUS/EUS (B) Year: 2016 The value of bacterial culture in patients with suspected lung cancer evaluated by bronchoscopy: A prospective study of 155 patients Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014